Work

Effect of Deferasirox (Exjade®) on Labile Plasma Iron Levels in Heavily Iron-Overloaded Patients with Transfusion-Dependent Anemias Enrolled in the Large-Scale, Prospective 1-Year EPIC Trial

Year: 2008

Type: article

Source: Blood

DOI: 10.1182/blood.v112.11.3881.3881

Authors: John B Porter, Maria Domenica Cappellini, Amal El-Beshlawy, Antonis Kattamis, John F Seymour, Jong Wook Lee, Hanspeter Nick, Dany Habr, Gabor Domokos, Abdel Hmissi, Ali Taher

Institutions: University College London, University of Milan, Cairo University, National and Kapodistrian University of Athens, Peter MacCallum Cancer Centre, Catholic University of Korea, Novartis (Switzerland), Novartis (United States), American University of Beirut

Language: English

Topic: Iron Metabolism and Disorders

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W159611377

FWCI: 3.344

Cites:

Cited by: 19

Related to: 10